N. ESKIYURT Et Al. , "Open, prospective, multi-center, two-part study of patient preference with monthly ibandronate therapy in women with postmenopausal osteoporosis switched from daily or weekly alendronate or risendronate-BONCURE: Results of Turkish sub-study," Turk Osteoporoz Dergisi , vol.18, no.1, pp.1-7, 2012
ESKIYURT, N. Et Al. 2012. Open, prospective, multi-center, two-part study of patient preference with monthly ibandronate therapy in women with postmenopausal osteoporosis switched from daily or weekly alendronate or risendronate-BONCURE: Results of Turkish sub-study. Turk Osteoporoz Dergisi , vol.18, no.1 , 1-7.
ESKIYURT, N., Irdesel, J., Sepici, V., Uǧurlu, H., Kirazli, Y., Ardiç, F., ... Bütün, B.(2012). Open, prospective, multi-center, two-part study of patient preference with monthly ibandronate therapy in women with postmenopausal osteoporosis switched from daily or weekly alendronate or risendronate-BONCURE: Results of Turkish sub-study. Turk Osteoporoz Dergisi , vol.18, no.1, 1-7.
ESKIYURT, Nurten Et Al. "Open, prospective, multi-center, two-part study of patient preference with monthly ibandronate therapy in women with postmenopausal osteoporosis switched from daily or weekly alendronate or risendronate-BONCURE: Results of Turkish sub-study," Turk Osteoporoz Dergisi , vol.18, no.1, 1-7, 2012
ESKIYURT, Nurten Et Al. "Open, prospective, multi-center, two-part study of patient preference with monthly ibandronate therapy in women with postmenopausal osteoporosis switched from daily or weekly alendronate or risendronate-BONCURE: Results of Turkish sub-study." Turk Osteoporoz Dergisi , vol.18, no.1, pp.1-7, 2012
ESKIYURT, N. Et Al. (2012) . "Open, prospective, multi-center, two-part study of patient preference with monthly ibandronate therapy in women with postmenopausal osteoporosis switched from daily or weekly alendronate or risendronate-BONCURE: Results of Turkish sub-study." Turk Osteoporoz Dergisi , vol.18, no.1, pp.1-7.
@article{article, author={Nurten ESKIYURT Et Al. }, title={Open, prospective, multi-center, two-part study of patient preference with monthly ibandronate therapy in women with postmenopausal osteoporosis switched from daily or weekly alendronate or risendronate-BONCURE: Results of Turkish sub-study}, journal={Turk Osteoporoz Dergisi}, year=2012, pages={1-7} }